Skip to main content

GE Unit to Offer After-Market Services for Ciphergen

NEW YORK, Dec. 18 (GenomeWeb News) - A unit of General Electric will become Ciphergen Biosystems' post-sale services partner for its ProteinChip systems for hospitals in China, Hong Kong, and Taiwan, the companies said today.

 

Ciphergen and GE Medical Systems have been working together in Chinaon an "informal basis" for the past year, and have now established a "formal," multi-year services agreement. The agreement is with the Medical Systems' Trade and Development unit.

Financial and other terms of the agreement were not disclosed.

"GE Medical Systems has a major presence ... in China," William Rich, president and CEO of Ciphergen, said in a statement. "Chinais investing heavily in leading edge biotechnology research and we hope to jointly play a significant role in fostering the adoption of our ProteinChip products as research and diagnostic platforms in this important market."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.